371 related articles for article (PubMed ID: 33813748)
1. Loss-of-Function Genetic Screening Identifies Aldolase A as an Essential Driver for Liver Cancer Cell Growth Under Hypoxia.
Niu Y; Lin Z; Wan A; Sun L; Yan S; Liang H; Zhan S; Chen D; Bu X; Liu P; Chen C; He W; Lu X; Wan G
Hepatology; 2021 Sep; 74(3):1461-1479. PubMed ID: 33813748
[TBL] [Abstract][Full Text] [Related]
2. Fructose-Bisphosphate Aldolase A Regulates Hypoxic Adaptation in Hepatocellular Carcinoma and Involved with Tumor Malignancy.
Li X; Jiang F; Ge Z; Chen B; Yu J; Xin M; Wang J; An L; Wei J; Wu L
Dig Dis Sci; 2019 Nov; 64(11):3215-3227. PubMed ID: 31041640
[TBL] [Abstract][Full Text] [Related]
3. ZNF692 drives malignant development of hepatocellular carcinoma cells by promoting ALDOA-dependent glycolysis.
Meng W; Lu X; Wang G; Xiao Q; Gao J
Funct Integr Genomics; 2024 Mar; 24(2):53. PubMed ID: 38453820
[TBL] [Abstract][Full Text] [Related]
4. Aldolase A promotes epithelial-mesenchymal transition to increase malignant potentials of cervical adenocarcinoma.
Saito Y; Takasawa A; Takasawa K; Aoyama T; Akimoto T; Ota M; Magara K; Murata M; Hirohashi Y; Hasegawa T; Sawada N; Saito T; Osanai M
Cancer Sci; 2020 Aug; 111(8):3071-3081. PubMed ID: 32530543
[TBL] [Abstract][Full Text] [Related]
5. The antitumor role of a newly discovered α-d-glucan from Holotrichia diomphalia Bates as a selective blocker of aldolase A.
Wang J; Li Z; Yang X; Qiao Y; Feng C; Yu S; Jing H; Liu W; Ren L; Duan Q; Li XQ; Cao W
Carbohydr Polym; 2021 Mar; 255():117532. PubMed ID: 33436261
[TBL] [Abstract][Full Text] [Related]
6. Aldolase A as a prognostic factor and mediator of progression via inducing epithelial-mesenchymal transition in gastric cancer.
Jiang Z; Wang X; Li J; Yang H; Lin X
J Cell Mol Med; 2018 Sep; 22(9):4377-4386. PubMed ID: 29992789
[TBL] [Abstract][Full Text] [Related]
7. Fructose-bisphosphate aldolase A is a key regulator of hypoxic adaptation in colorectal cancer cells and involved in treatment resistance and poor prognosis.
Kawai K; Uemura M; Munakata K; Takahashi H; Haraguchi N; Nishimura J; Hata T; Matsuda C; Ikenaga M; Murata K; Mizushima T; Yamamoto H; Doki Y; Mori M
Int J Oncol; 2017 Feb; 50(2):525-534. PubMed ID: 28000858
[TBL] [Abstract][Full Text] [Related]
8. MKL-1-induced PINK1-AS overexpression contributes to the malignant progression of hepatocellular carcinoma via ALDOA-mediated glycolysis.
Wang J; Zhang HM; Dai ZT; Huang Y; Liu H; Chen Z; Wu Y; Liao XH
Sci Rep; 2022 Dec; 12(1):21283. PubMed ID: 36494481
[TBL] [Abstract][Full Text] [Related]
9. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-induced myeloid derived growth factor promotes hepatocellular carcinoma progression through remodeling tumor microenvironment.
Wang X; Mao J; Zhou T; Chen X; Tu H; Ma J; Li Y; Ding Y; Yang Y; Wu H; Tang X
Theranostics; 2021; 11(1):209-221. PubMed ID: 33391471
[No Abstract] [Full Text] [Related]
11. Yes-associated protein (YAP) binds to HIF-1α and sustains HIF-1α protein stability to promote hepatocellular carcinoma cell glycolysis under hypoxic stress.
Zhang X; Li Y; Ma Y; Yang L; Wang T; Meng X; Zong Z; Sun X; Hua X; Li H
J Exp Clin Cancer Res; 2018 Sep; 37(1):216. PubMed ID: 30180863
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia Causes Downregulation of Dicer in Hepatocellular Carcinoma, Which Is Required for Upregulation of Hypoxia-Inducible Factor 1α and Epithelial-Mesenchymal Transition.
Ibrahim AA; Schmithals C; Kowarz E; Köberle V; Kakoschky B; Pleli T; Kollmar O; Nitsch S; Waidmann O; Finkelmeier F; Zeuzem S; Korf HW; Schmid T; Weigert A; Kronenberger B; Marschalek R; Piiper A
Clin Cancer Res; 2017 Jul; 23(14):3896-3905. PubMed ID: 28167508
[No Abstract] [Full Text] [Related]
13. Feedback regulation of ALDOA activates the HIF-1α/MMP9 axis to promote lung cancer progression.
Chang YC; Chan YC; Chang WM; Lin YF; Yang CJ; Su CY; Huang MS; Wu ATH; Hsiao M
Cancer Lett; 2017 Sep; 403():28-36. PubMed ID: 28610954
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of the ALDOA/DNA-PK/p53 pathway by dietary restriction suppresses tumor growth.
Ma D; Chen X; Zhang PY; Zhang H; Wei LJ; Hu S; Tang JZ; Zhou MT; Xie C; Ou R; Xu Y; Tang KF
Oncogene; 2018 Feb; 37(8):1041-1048. PubMed ID: 29084207
[TBL] [Abstract][Full Text] [Related]
15. Aldolase A promotes proliferation and G
Fu H; Gao H; Qi X; Zhao L; Wu D; Bai Y; Li H; Liu X; Hu J; Shao S
Cancer Commun (Lond); 2018 May; 38(1):18. PubMed ID: 29764507
[TBL] [Abstract][Full Text] [Related]
16. The hypoxia conditioned mesenchymal stem cells promote hepatocellular carcinoma progression through YAP mediated lipogenesis reprogramming.
Liu Y; Ren H; Zhou Y; Shang L; Zhang Y; Yang F; Shi X
J Exp Clin Cancer Res; 2019 May; 38(1):228. PubMed ID: 31142342
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia activates Wnt/β-catenin signaling by regulating the expression of BCL9 in human hepatocellular carcinoma.
Xu W; Zhou W; Cheng M; Wang J; Liu Z; He S; Luo X; Huang W; Chen T; Yan W; Xiao J
Sci Rep; 2017 Jan; 7():40446. PubMed ID: 28074862
[TBL] [Abstract][Full Text] [Related]
18. Bclaf1 promotes angiogenesis by regulating HIF-1α transcription in hepatocellular carcinoma.
Wen Y; Zhou X; Lu M; He M; Tian Y; Liu L; Wang M; Tan W; Deng Y; Yang X; Mayer MP; Zou F; Chen X
Oncogene; 2019 Mar; 38(11):1845-1859. PubMed ID: 30367150
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia upregulates Rab11-family interacting protein 4 through HIF-1α to promote the metastasis of hepatocellular carcinoma.
Hu F; Deng X; Yang X; Jin H; Gu D; Lv X; Wang C; Zhang Y; Huo X; Shen Q; Luo Q; Zhao F; Ge T; Zhao F; Chu W; Shu H; Yao M; Fan J; Qin W
Oncogene; 2015 Dec; 34(49):6007-17. PubMed ID: 25745995
[TBL] [Abstract][Full Text] [Related]
20. The role of fructose 1,6-bisphosphate-mediated glycolysis/gluconeogenesis genes in cancer prognosis.
Li CH; Chan MH; Chang YC
Aging (Albany NY); 2022 Apr; 14(7):3233-3258. PubMed ID: 35404841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
